Alnylam Pharmaceuticals (ALNY) PT Lowered to $111 at Stifel
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $245.51 +2.57%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 10 | New: 43
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 10 | New: 43
Join SI Premium – FREE
Stifel analyst Paul Matteis lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $111.00 (from $117.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$236 at Bernstein SocGen Group
- Sirius XM Radio (SIRI) PT Raised to $37 at Guggenheim
- Chord Energy Corp (CHRD) PT Raised to $180 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
